Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Leishmaniasis, Cutaneous

pyrrolidine dithiocarbamate has been researched along with Leishmaniasis, Cutaneous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borghi, SM; Casagrande, R; Fattori, V; Miranda-Sapla, MM; Pavanelli, WR; Pinge-Filho, P; Ruiz-Miyazawa, KW; Verri, WA	1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Leishmaniasis, Cutaneous

Article	Year
Leishmania (L). amazonensis induces hyperalgesia in balb/c mice: Contribution of endogenous spinal cord TNFα and NFκB activation. Chemico-biological interactions, 2017, Apr-25, Volume: 268 Topics: Adalimumab; Animals; Etanercept; Hyperalgesia; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Mice, Inbred BALB C; Morphine; NF-kappa B; Parasite Load; Pyrrolidines; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; RNA, Messenger; Spinal Cord; Thiocarbamates; Tumor Necrosis Factor-alpha	2017

Article

Year

Leishmania (L). amazonensis induces hyperalgesia in balb/c mice: Contribution of endogenous spinal cord TNFα and NFκB activation.

Chemico-biological interactions, 2017, Apr-25, Volume: 268

Topics: Adalimumab; Animals; Etanercept; Hyperalgesia; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Mice, Inbred BALB C; Morphine; NF-kappa B; Parasite Load; Pyrrolidines; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; RNA, Messenger; Spinal Cord; Thiocarbamates; Tumor Necrosis Factor-alpha

2017